First Alzheimer's patients test new brain drug
Disease control
Recruiting now
This early-stage study is testing whether a new drug called THN391 is safe for people with early Alzheimer's disease. Fifteen participants aged 65-85 will receive either the drug or a placebo injection three times over two months, followed by four months of monitoring. Researcher…
Phase: PHASE1 • Sponsor: Therini Bio, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC